These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38353701)

  • 21. The Role of the VP4 Attachment Protein in Rotavirus Host Range Restriction in an
    Sánchez-Tacuba L; Kawagishi T; Feng N; Jiang B; Ding S; Greenberg HB
    J Virol; 2022 Aug; 96(15):e0055022. PubMed ID: 35862708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tandem truncated rotavirus VP8* subunit protein with T cell epitope as non-replicating parenteral vaccine is highly immunogenic.
    Wen X; Cao D; Jones RW; Hoshino Y; Yuan L
    Hum Vaccin Immunother; 2015; 11(10):2483-9. PubMed ID: 26091081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human VP8* mAbs neutralize rotavirus selectively in human intestinal epithelial cells.
    Feng N; Hu L; Ding S; Sanyal M; Zhao B; Sankaran B; Ramani S; McNeal M; Yasukawa LL; Song Y; Prasad BVV; Greenberg HB
    J Clin Invest; 2019 Aug; 129(9):3839-3851. PubMed ID: 31403468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus.
    Xia M; Wei C; Wang L; Cao D; Meng XJ; Jiang X; Tan M
    Sci Rep; 2016 May; 6():25735. PubMed ID: 27194006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative In Vitro and In Vivo Studies of Porcine Rotavirus G9P[13] and Human Rotavirus Wa G1P[8].
    Shao L; Fischer DD; Kandasamy S; Rauf A; Langel SN; Wentworth DE; Stucker KM; Halpin RA; Lam HC; Marthaler D; Saif LJ; Vlasova AN
    J Virol; 2016 Jan; 90(1):142-51. PubMed ID: 26468523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inclusion of a universal tetanus toxoid CD4(+) T cell epitope P2 significantly enhanced the immunogenicity of recombinant rotavirus ΔVP8* subunit parenteral vaccines.
    Wen X; Wen K; Cao D; Li G; Jones RW; Li J; Szu S; Hoshino Y; Yuan L
    Vaccine; 2014 Jul; 32(35):4420-4427. PubMed ID: 24962749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin.
    Fiore L; Greenberg HB; Mackow ER
    Virology; 1991 Apr; 181(2):553-63. PubMed ID: 1849677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization and protective efficacy in an animal model of a novel truncated rotavirus VP8 subunit parenteral vaccine candidate.
    Xue M; Yu L; Che Y; Lin H; Zeng Y; Fang M; Li T; Ge S; Xia N
    Vaccine; 2015 May; 33(22):2606-13. PubMed ID: 25882173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological response to recombinant VP8* subunit protein of bovine roravirus in pregnant cattle.
    Lee J; Babiuk LA; Harland R; Gibbons E; Elazhary Y; Yoo D
    J Gen Virol; 1995 Oct; 76 ( Pt 10)():2477-83. PubMed ID: 7595351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity, antigenicity, and protection efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(1)* and VP8* from rhesus rotavirus.
    Dunn SJ; Fiore L; Werner RL; Cross TL; Broome RL; Ruggeri FM; Greenberg HB
    Arch Virol; 1995; 140(11):1969-78. PubMed ID: 7503695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of Sialic Acid-Independent Simian Rotavirus Mutants in Viral Infection and Pathogenesis.
    Yamasaki M; Kanai Y; Wakamura Y; Kotaki T; Minami S; Nouda R; Nurdin JA; Kobayashi T
    J Virol; 2023 Jan; 97(1):e0139722. PubMed ID: 36602365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial.
    Groome MJ; Fairlie L; Morrison J; Fix A; Koen A; Masenya M; Jose L; Madhi SA; Page N; McNeal M; Dally L; Cho I; Power M; Flores J; Cryz S
    Lancet Infect Dis; 2020 Jul; 20(7):851-863. PubMed ID: 32251641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation and characterization of mouse monoclonal antibodies against the VP4 protein of group A human rotaviruses.
    Zeng Y; Song F; Luo G; Yang H; Li C; Liu W; Li T; Zhang S; Wang Y; Huang C; Ge S; Zhang J; Xia N
    Antiviral Res; 2022 Nov; 207():105407. PubMed ID: 36152816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mRNA-Based Vaccines Are Highly Immunogenic and Confer Protection in the Gnotobiotic Pig Model of Human Rotavirus Diarrhea.
    Hensley C; Roier S; Zhou P; Schnur S; Nyblade C; Parreno V; Frazier A; Frazier M; Kiley K; O'Brien S; Liang Y; Mayer BT; Wu R; Mahoney C; McNeal MM; Petsch B; Rauch S; Yuan L
    Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Location of intrachain disulfide bonds in the VP5* and VP8* trypsin cleavage fragments of the rhesus rotavirus spike protein VP4.
    Patton JT; Hua J; Mansell EA
    J Virol; 1993 Aug; 67(8):4848-55. PubMed ID: 8392619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation and preclinical studies with a trivalent rotavirus P2-VP8 subunit vaccine.
    Lakatos K; McAdams D; White JA; Chen D
    Hum Vaccin Immunother; 2020 Aug; 16(8):1957-1968. PubMed ID: 31995444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal and systemic neutralizing antibodies to norovirus induced in infant mice orally inoculated with recombinant rotaviruses.
    Kawagishi T; Sánchez-Tacuba L; Feng N; Costantini VP; Tan M; Jiang X; Green KY; Vinjé J; Ding S; Greenberg HB
    Proc Natl Acad Sci U S A; 2023 Feb; 120(9):e2214421120. PubMed ID: 36821582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of P[8], P[4], and P[6] VP8* genes of human rotaviruses globally reported during 1974 and 2017: possible implications for rotavirus vaccines in development.
    Velasquez DE; Jiang B
    Hum Vaccin Immunother; 2019; 15(12):3003-3008. PubMed ID: 31124743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma VP8∗-Binding Antibodies in Rotavirus Infection and Oral Vaccination in Young Bangladeshi Children.
    Lee B; Colgate ER; Carmolli M; Dickson DM; Gullickson S; Diehl SA; Ara R; Alam M; Kibria G; Abdul Kader M; Afreen S; Ferdous T; Haque R; Kirkpatrick BD
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):127-133. PubMed ID: 34904667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a live attenuated trivalent porcine rotavirus A vaccine against disease caused by recent strains most prevalent in South Korea.
    Park JG; Alfajaro MM; Cho EH; Kim JY; Soliman M; Baek YB; Park CH; Lee JH; Son KY; Cho KO; Kang MI
    Vet Res; 2019 Jan; 50(1):2. PubMed ID: 30616694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.